Table 1.
Demographic characteristics and HIV care among PLHIV in China responding to a nationwide online survey during the COVID‐19 outbreak
| Characteristics |
Total (N = 5084) n (%) |
No risk of ATI (N = 3302) n (%) |
Threatened but resolved risk of ATI (N = 730) n (%) |
Risk of imminent ATI (N = 917) n (%) |
Experienced ATI (N = 135) n (%) |
P value |
|---|---|---|---|---|---|---|
| Sex | 0.526 | |||||
| Male | 4904 (96.46) | 3179 (96.27) | 711 (97.40) | 884 (96.40) | 130 (96.30) | |
| Female | 180 (3.54) | 123 (3.73) | 19 (2.60) | 33 (3.60) | 5 (3.70) | |
| Age, year | <0.001 | |||||
| 18 to 29 | 2092 (41.15) | 1267 (38.37) | 336 (46.03) | 417 (45.47) | 72 (53.33) | |
| 30 to 39 | 2063 (40.58) | 1376 (41.67) | 289 (39.59) | 349 (38.06) | 49 (36.30) | |
| ≥40 | 929 (18.27) | 659 (19.96) | 105 (14.38) | 151 (16.47) | 14 (10.37) | |
| Education | <0.001 | |||||
| College or above | 3647 (71.73) | 2366 (71.65) | 583 (79.86) | 606 (66.09) | 92 (68.15) | |
| High school or below | 1437 (28.27) | 936 (28.35) | 147 (20.14) | 311 (33.91) | 43 (31.85) | |
| Occupation | <0.001 | |||||
| Student | 364 (7.16) | 193 (5.84) | 59 (8.08) | 102 (11.12) | 10 (7.41) | |
| Farmer | 218 (4.29) | 126 (3.82) | 26 (3.56) | 57 (6.22) | 9 (6.67) | |
| Employed | 4073 (80.11) | 2674 (80.98) | 610 (83.56) | 683 (74.48) | 106 (78.52) | |
| Unemployed | 429 (8.44) | 309 (9.36) | 35 (4.79) | 75 (8.18) | 10 (7.41) | |
| Salary (RMB) | <0.001 | |||||
| <2000 | 923 (18.15) | 565 (17.11) | 112 (15.34) | 217 (23.66) | 29 (21.48) | |
| 2000 to 4999 | 1920 (37.77) | 1285 (38.92) | 234 (32.05) | 338 (36.86) | 63 (46.67) | |
| 5000 to 9999 | 1553 (30.55) | 999 (30.25) | 253 (34.66) | 267 (29.12) | 34 (25.19) | |
| ≥10000 | 688 (13.53) | 453 (13.72) | 131 (17.95) | 95 (10.36) | 9 (6.67) | |
| HIV transmission route | 0.010 | |||||
| Male‐male sex | 3627 (71.34) | 2379 (72.05) | 542 (74.25) | 607 (66.19) | 99 (73.33) | |
| Male‐female sex | 499 (9.82) | 315 (9.54) | 65 (8.90) | 109 (11.89) | 10 (7.41) | |
| Other or not sure | 958 (18.84) | 608 (18.41) | 123 (16.85) | 201 (21.92) | 26 (19.26) | |
| CD4 cell count (per ul) at HIV diagnosis a | 0.057 | |||||
| <200 | 1103 (21.73) | 753 (22.84) | 135 (18.52) | 187 (20.41) | 28 (20.74) | |
| 200 to 349 | 1574 (31.00) | 1022 (31.00) | 225 (30.86) | 294 (32.10) | 33 (24.44) | |
| 350 to 499 | 1305 (25.70) | 813 (24.66) | 198 (27.16) | 248 (27.07) | 46 (34.07) | |
| ≥500 | 1095 (21.57) | 709 (21.50) | 171 (23.46) | 187 (20.41) | 28 (20.74) | |
| Viral load at last test | 0.001 | |||||
| Undetectable | 3946 (77.62) | 2599 (78.71) | 583 (79.86) | 672 (73.28) | 92 (68.15) | |
| Detectable | 344 (6.77) | 211 (6.39) | 42 (5.75) | 78 (8.51) | 13 (9.63) | |
| Not sure | 794 (15.62) | 492 (14.90) | 105 (14.38) | 167 (18.21) | 30 (22.22) | |
| Source of ART | 0.001 | |||||
| Free government‐sponsored ART | 4567 (89.83) | 2940 (89.04) | 647 (88.63) | 855 (93.24) | 125 (92.59) | |
| Purchase out of pocket | 268 (5.27) | 201 (6.09) | 40 (5.48) | 25 (2.73) | 2 (1.48) | |
| Both | 249 (4.90) | 161 (4.88) | 43 (5.89) | 37 (4.03) | 8 (5.93) | |
| Ever obtained ART via postage | <0.001 | |||||
| Yes | 1542 (30.33) | 909 (27.53) | 345 (47.26) | 238 (25.95) | 50 (37.04) | |
| No | 3542 (69.67) | 2393 (72.47) | 385 (52.74) | 679 (74.05) | 85 (62.96) | |
RMB 100 ≈ USD 14. The bold values are statistically significant (P < 0.05) in Pearson’s Chi‐squared test. HIV transmission reclassified for multiple choices of “Your route of HIV transmission”, HIV transmission of “intravenous drug use”, “Former commercial blood donors”, “Mother‐to‐child”, “Other”, “Not sure” classified as “Other or not sure”. ART, antiretroviral therapy; ATI, antiretroviral therapy interruption; PLHIV, people living with HIV.
7 missing.